My BPC 157 nasal spray looks cloudy
Poster Session I - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.03 - PROGNOSIS AND OUTCOME AFTER STROKE P227 - ESOC25-178 HEALTH RELATED QUALITY (EQ-5D-3L) AMONG PATIENTS WITH DIFFERENT FUNCTIONAL OUTCOME (GOSE) A YEAR AFTER ANEURYSMAL SUBARACHNOID HAEMORRHAGE IN A SWEDISH NATIONAL COHORT - TARGETING HIDDEN NEEDS Helena Aineskog 1 , Elisabeth Ronne Engstrm 2 , Bryndis Baldvinsdttir 3 , Asgeir Jakola 4 , Ola Nilsson 3 , Mikael Svensson 5 , Peter Alpkvist 5 , Jan Hillman 6 , Peter Lindvall 1 1 Department of Clinical Sciences - Neurosciences, Ume University, Ume, Sweden, 2 Department of Medical Sciences - Neurosurgery, Uppsala, Sweden, 3 Department of Clinical Sciences - Neurosurgery, Lund, Sweden, 4 Department of Clinical Neuroscience, University of Gothenburg, Gothenburg, Sweden, 5 Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden, 6 Department of Clinical Sciences, Linkping University, Linkoping, Sweden Background and Aims: Aneurysmal subarachnoid hemorrhage (aSAH) is a devastating condition and improving health related quality of life (HRQoL), a central goal
Who Is the Right Candidate for Tesamorelin
Testosterone enanthate is also administered through intramuscular injections and has a similar purpose of supplementing testosterone levels in the body to address symptoms of low testosterone
Disclosure of interest: none E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.02 - SECONDARY PREVENTION P2464 - ESOC25-245 NON-PERSISTENCE TO ORAL ANTICOAGULATION IS ASSOCIATED WITH ADVERSE CLINICAL OUTCOMES WITHIN 24 MONTHS AFTER ISCHAEMIC STROKE OR TIA IN REGISTRY PATIENTS WITH ATRIAL FIBRILLATION Manuel C
